Bioventus Inc (BVS)
14.12
+0.54
(+3.98%)
USD |
NASDAQ |
Nov 04, 13:16
Bioventus Profit Margin (Quarterly): -15.87% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -15.87% |
| March 31, 2024 | -3.53% |
| December 31, 2023 | -4.50% |
| September 30, 2023 | -6.05% |
| June 30, 2023 | -2.69% |
| March 31, 2023 | -116.9% |
| December 31, 2022 | -25.37% |
| September 30, 2022 | -84.13% |
| June 30, 2022 | -5.17% |
| March 31, 2022 | -9.61% |
| December 31, 2021 | -0.28% |
| Date | Value |
|---|---|
| September 30, 2021 | -0.98% |
| June 30, 2021 | -3.76% |
| March 31, 2021 | 30.49% |
| December 31, 2020 | 2.82% |
| September 30, 2020 | 9.84% |
| June 30, 2020 | -9.94% |
| March 31, 2020 | 13.92% |
| December 31, 2019 | 5.78% |
| March 31, 2016 | -9.25% |
| March 31, 2015 | -39.39% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-116.9%
Minimum
Mar 2023
30.49%
Maximum
Mar 2021
-11.89%
Average
-3.76%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| Insulet Corp | 38.61% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | -12.89% |
| Catheter Precision Inc | -4.54K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -19.29% |
| Return on Assets | -5.19% |
| Return on Invested Capital | -6.91% |
| Gross Profit Margin (Quarterly) | 68.54% |
| Operating Margin (Quarterly) | 1.85% |
| Return on Net Operating Assets | -5.58% |